Navigation Links
Ikaria® Appoints Chief Medical Officer
Date:4/11/2012

HAMPTON, N.J., April 11, 2012 /PRNewswire/ -- Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today announced that Joseph Stauffer, D.O., has been appointed Chief Medical Officer.  In this role, Dr. Stauffer will be responsible for all medical, patient safety, risk management, and regulatory activities related to Ikaria's commercialized product, INOMAX® (nitric oxide) for inhalation, as well as future launch products.

"We are delighted to welcome Joe, whose extensive medical leadership experience will be of great benefit to the many aspects of our unique INOMAX offering," commented Daniel Tasse, Chairman and CEO of Ikaria. "We believe his previous experience in pharmaceuticals and at the FDA provide him with a unique opportunity to view our products with an exquisite balance of medical insight, business acumen and regulatory compliance."

Dr. Stauffer most recently held the position of Chief Medical Officer at PharmacoFore, a California-based biopharmaceutical company.  Prior to that, he was Chief Medical Officer at DURECT Corporation, a specialty pharmaceutical company, and at Alpharma/King Pharmaceuticals.  He began his pharmaceutical career at Abbott Laboratories in 2002, where he was global medical director for its pain portfolio.  Dr. Stauffer also served as a medical officer in the Analgesic Division of the FDA's Center for Drug Evaluation and Research from 2000-2002, where he reviewed Investigational New Drug (IND) Applications and New Drug Applications (NDAs) for opiate, non-opiate, anti-inflammatory and novel pain compounds.  He graduated from the Philadelphia College of Osteopathic Medicine and completed residency training in Anesthesiology at the Johns Hopkins University Hospital where he is currently an Adjunct Assistant Professor in the Department of Anesthesiology and Critical Care Medicine. Additionally, he completed hi
'/>"/>

SOURCE Ikaria, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ikaria® Completes Patient Enrollment in Pivotal Phase III Trial for Bronchopulmonary Dysplasia
2. Ikaria® to Present at 14th Annual BIO CEO & Investor Conference
3. Ikaria® to Present at 2011 BIO Investor Forum
4. Ikaria® To Present at 2011 BIO Business Forum and International Convention
5. Campbell Alliance Launches Market Research and Analytics Group, Appoints Michael Turner as General Manager of Encuity Research
6. Amarillo Biosciences Appoints Dr. Stephen Chen as Chairman and CEO
7. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
8. InspireMD Appoints Dr. James Barry to Its Board of Directors
9. Veracyte Appoints Mark Spring as Chief Financial Officer
10. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
11. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of ... regulatory, business, and media events in the United States ... former associate Virginia Cox , JD, is returning to the ... Virginia Cox re-joins 3D after more than two years of ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. 14, ... with two institutes from the National Institutes of Health ... bringing safer, more effective treatments to patients on a ... for Advancing Translational Sciences (NCATS) and the National Eye ...
(Date:1/14/2014)... January 14, 2014 Global Record ... innovative information technology solutions for patients, physicians, the ... stakeholders, announced today the signing of a three-year ... and Drug Administration (FDA). This initiative is ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... SINGAPORE, Sept. 14 China Agro-Technology Holdings (OTC Bulletin Board: ... is focused on spotlighting the company,s focus on acquiring high-growth ... located at www.chinaagrotech.com. , , About ... headquartered in Singapore, is focused on becoming a leader in ...
... , , Intelligent Design Author Will Also Speak ... , Sept. 14 The debate over Darwin rages on in ... of Natural History September 29th with the Southwestern debut of ... in the fossil record. To view a trailer and clips from the ...
... , SUNNYVALE, Calif., Sept. 14 ... focused on developing and commercializing innovative small molecule drugs for ... that it will report financial results for the fourth quarter ... market closes on Thursday September 17, 2009 at 1:30 p.m. ...
Cached Biology Technology:Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29 2Pharmacyclics Announces Date of Fourth Quarter and Fiscal Year End 2009 Conference Call 2
(Date:7/9/2014)... fit in terms of cardiorespiratory capacity, strength and ... adolescents are more obese and present higher levels ... the centre-north of Europe. , These are some ... conducted by scientists from the University of Granada ... other European research groups. The study compared the ...
(Date:7/9/2014)... cell divides, it must first make a copy of its ... that occurs billions of times a day in the human ... tools that cells use to replicate DNAthe enzymes that unzip ... a clear picture of how the process works. , Now, ... to decipher what goes on at the "replication fork"the point ...
(Date:7/8/2014)... Collectors found the first two specimens of the prickly plant ... decades, the 14-inch-tall plant was identified wrongly as one species, ... a long search turned up a "pathetic, wilted" third specimen ... the spiny plant as a new, possibly endangered species and ... found in Valentine, Texas, population 134 in 2010. , Most ...
Breaking Biology News(10 mins):Adolescents from southern Europe are less fit and more obese than central-northern European peers 2Rockefeller scientists first to reconstitute the DNA 'replication fork' 2Rockefeller scientists first to reconstitute the DNA 'replication fork' 3Rockefeller scientists first to reconstitute the DNA 'replication fork' 4New plant species from the heart of Texas 2New plant species from the heart of Texas 3New plant species from the heart of Texas 4New plant species from the heart of Texas 5
... of North Carolina at Chapel Hill have identified a new ... practice. In an article published in the ... researchers describe how exploiting the molecular mechanism behind acupuncture resulted ... new therapeutic approach PAPupuncture. Principal investigator Mark ...
... defects of the brain and spine in America,s babies, particularly those of Hispanic ... with the B vitamin folic acid, according to a new petition filed with ... , Gruma Corporation Spina ... March of Dimes Foundation , ...
... surgery appears to be associated with an increased risk of ... a new study at the Sahlgrenska Academy, at the University ... is the most important factor when it comes to adhesive ... operations and other health conditions into account. This is ...
Cached Biology News:Pain relief with PAP injections may last 100 times longer than a traditional acupuncture treatment 2Coalition petitions FDA to fortify corn masa flour with folic acid 2Coalition petitions FDA to fortify corn masa flour with folic acid 3
... Cycler unit is an inexpensive personal or mini ... PCR process. Lightweight, with a small footprint, it ... including the researcher's desk. , The Gene Cycler ... do not have access to a large laboratory ...
... Select Immunophosphatase Secondary Detection System is intended ... Prediluted Primary Antibody reagents, which contain rat ... of antigens by light microscopy in paraffin-embedded ... System may also be used with other ...
... RNA stain is used to stain and ... agarose gels and does not interfere with ... nm transilluminator, the stain emits a red-orange ... film or with a CCD camera-based gel ...
... efficient interfacing with mass spectrometry. Improved ... demands for benefits like these have ... routine applications. Standard HPLC systems, however, ... to operate with smaller bore columns ...
Biology Products: